| 摘要 |
<p>The present invention relates to materials and methods for the diagnosis and treatment of B-cell chronic lymphocytic leukaemia (BCLL). The present invention relates to a method of treating BCLL in an individual comprising modulating the expression of the CLLD8 and/or the NY-REN-34 gene.</p> |
